| |
 |
|
|
| |
In 2005 Boston Millennia Partners continued to build
upon prior years’ accomplishments and established solid
momentum in value creation for our investors. Two portfolio
companies were acquired, another company went public and is
trading above its IPO price, and many encouraging events
unfolded within the Millennia portfolio. The venture industry
is vibrant and we are pleased to highlight a few of the
positive developments of which our investors can be proud.
Portfolio Company Highlights:
- CombinatoRx (NASDAQ: CRXX) completed
its initial public offering on November 9, 2005 selling
approximately 6 million shares at $7.00 per share.
CombinatoRx is currently trading up over 50%. CombinatoRx is
a biopharmaceutical company focused on developing new
medicines built from synergistic combinations of approved
drugs designed to attack disease on multiple
fronts.
In October, CombinatoRx and Angiotech
Pharmaceuticals, Inc. (NASDAQ: ANPI), a Canada-based
specialty pharmaceutical company, announced a multi-year
research and license agreement with a potential value of
more than $500 million. Angiotech paid an upfront license
fee to CombinatoRx and made an equity investment in
CombinatoRx. Angiotech licensed a number of CombinatoRx
compounds in return for attractive royalty
payments.
- Arthrosurface has developed a less
invasive joint resurfacing system intended to repair lesions
and cartilage damage in major bodily joints including knees,
hips, shoulders and the great toe. The company continues to
grow sales of its hip, shoulder and toe implants in the US
and of its hip, shoulder and knee implants outside the US.
Millennia led a $10.5 million Series D stock financing of
Arthrosurface in the first quarter of
2005.
- Nexidia is the leading provider of
scalable audio mining and speech analytics software. By
transforming audio data into actionable intelligence,
Nexidia’s technology offers a consistent and efficient means
for extracting information previously locked away in audio
files.
The company has been featured in various
magazines such as Red Herring and Information Week, as well
as other industry publications, and was recently named one
of the Red Herring 100 Private Companies of North America.
Since the start of 2005, Nexidia has been honored by the
following organizations:
- Software & Information Industry Association –
Selected as a Codie Awards finalist for the second
consecutive year in the category of “Best Enterprise
Search Engine”
- KM World – Named to the list of “100 Companies that
Matter” in knowledge management
- Customer Interaction Solutions Magazine – Received
Speech Technology Excellence and IP Contact Center
Technology Pioneer Award
- Optical Solutions (OSI), a worldwide
leader in fiber-to-the-home/to-the-building solutions
("FTTP"), announced in November that it will be acquired by
Calix, the industry leader in broadband
loop carrier (BLC) products. The addition of Optical
Solutions' standards-based, field-proven GPON products to
the Calix portfolio of access solutions creates a
market-leading access powerhouse. According to Infonetics
Research, Calix and Optical Solutions occupy the #1
positions in their respective markets. In the second quarter
of 2005 Calix claimed the top slot for broadband loop
carrier shipments for the eighth straight quarter while
Optical Solutions continued to extend its lead in FTTP GPON
deployments. Together, with over 70 production IPTV
deployments and more than 175 revenue-generating FTTP
customers among the joint installed base of over 300 service
providers, the company will be servicing and delivering a
much broader and more complete range of field-proven
solutions.
- P&H Solutions, the market leader in
Web-based corporate cash management to financial
institutions throughout North America, was named a top 100
Financial Technology Company by American Banker and research
firm Financial Insights in their annual international
listing of the top vertical technology vendors that derive
more than one third of their revenue from financial
services.
P&H signed a major, five-year contract
with The Sovereign Bank to put all Sovereign’s customers,
both commercial and consumer, on a single P&H platform.
This contract continues the rapid growth of P&H and
confirms its status as the market leader in providing
Web-based cash management services to financial
institutions. With this contract, bookings have surged well
ahead of last year's pace, positioning P&H for strong,
sustainable profitable growth.
Sale of
Cornerstone Brands:
- In a noteworthy event for one of our legacy funds,
Cornerstone Brands was acquired by
IAC/InteractiveCorp (NASDAQNM: IACI) for $720
million in April 2005. The company was built to a
value of almost three-quarters of a billion dollars in just
over 10 years, and generated close to a 10X return for our
previous fund investors using a Core Company consolidation
strategy. This success demonstrates the long maturation
process that can be required for extraordinary investment
results.
Portfolio Company Liquidity
Events:
- Yantra Corporation was acquired for
$170 million in cash by Sterling Commerce, a wholly owned
subsidiary of AT&T Corp. (NYSE: T). The transaction
combines Yantra, the leading provider of distributed order
management and supply chain fulfillment solutions, with
Sterling Commerce, which offers a variety of integration
software and hosted electronic-trading-network services.
Sterling Commerce is incorporating Yantra's application
suite into its Multi-Enterprise Services Architecture, a
supply-chain platform that businesses use to more closely
collaborate with each other.
- Totality, a provider of remote managed
services for business-critical applications and
infrastructure, was acquired by Verizon Communications Inc.
(NYSE: VZ). With this acquisition, Verizon enhanced its core
hosting capabilities with Totality’s proven expertise in the
applications management space, accelerating Verizon’s
ability to keep pace with customers as they transition to
IP. The acquisition was completed in September.
Selected Portfolio Company Financings:
- Athenix, a leading biotechnology
company developing novel products, technologies, and
processes for agricultural and chemical applications,
received $13 million in a Series C stock financing. A new
class of genes that Athenix discovered not only makes crops
more herbicide resistant, but can also be combined with
other yield improving traits like insect and grub
resistance. The worldwide market for herbicide resistant
crops exceeds $1 billion and is growing rapidly.
- CardioMEMS raised $16 million in a
Series C stock financing, as part of a partnering agreement
with Medtronic (NYSE: MDT). CardioMEMs is the leading
developer of innovative wireless medical pressure sensors
for the management of Abdominal Aortic Aneurysm (AAA) and
Heart Failure (HF) disease. CardioMEMS announced in November
US Food and Drug Administration (FDA) clearance and US
market launch of the EndoSure™ Wireless AAA Pressure
Measurement System. FDA clearance was based upon completion
of a multi-center, international clinical study in which
over 100 patients in Brazil, Argentina, Canada and at nine
hospitals in the United States successfully received an
EndoSure sensor at the same time they had a stent-graft
inserted to repair their aortic aneurysms.
- Millennia was the sole investor in a Series B stock
financing for Collegium Pharmaceutical, a
leading specialty pharmaceutical company focused on the
development of proprietary, late stage pharmaceutical
products. Collegium applies customized pharmaceutical
formulations and IP strategies to active ingredients that
have been shown to be safe and effective, creating a
portfolio of improved pharmaceutical products with
potentially less development risk and shorter times to
market.
- Glycofi raised $11 million in a Series
C stock financing. GlycoFi leverages its pioneering protein
optimization technology to develop, produce and
commercialize next generation biotherapeutics, alone and in
partnership with other leading biopharmaceutical companies.
This past quarter, GlycoFi announced a broad strategic
alliance and multi-year research collaboration with Merck
& Co., Inc. and an agreement with Eli Lilly &
Company to initiate research on 10 protein optimization
programs over the extendable two-year research term. Both
companies plan to integrate GlycoFi’s technology platform
internally and both have agreed to make equity investments
in GlycoFi. For more details see GlycoFi’s web site at http://www.glycofi.com/.
- Netifice Communications, a leading
provider of flexible IP Virtual Private Network (VPN)
solutions to businesses worldwide, raised $55 million in a
new round of funding. Simultaneously with the funding,
Netifice acquired the managed SSL VPN services business of
Aventail Corporation. This acquisition makes Netifice the
largest provider of managed SSL VPN services and the only US
managed service provider capable of providing a full range
of integrated remote access and site-to-site IP VPN
services, including SSL, IPSec and MPLS.
- Novalar Pharmaceuticals, an early-stage
pharmaceutical company, raised $27 million in a Series C
private equity financing. The company's initial product
offering, NV-101, has been developed to rapidly reverse the
oral numbness associated with the local dental anesthesia.
In November, the company passed a key milestone by receiving
written FDA approval of the pivotal Phase III clinical trial
protocols for NV-101.
- Predix Pharmaceuticals raised $43
million in a Series C private equity financing. Predix is a
clinical stage drug development company that uses a
proprietary discovery and lead optimization platform to
focus on G-protein coupled receptors (GPCRs) and ion channel
drug targets. Using its proprietary drug discovery
technology and approach, Predix has progressed three drug
candidates into clinical trials and has six additional
programs in preclinical development and discovery.
- Tropos Networks completed a Series E
stock financing. Tropos is the leading supplier of equipment
used to build metro-scale Wi-Fi mesh networks. Tropos has
more than 250 customer deployments, including recent major
city-wide wins in Philadelphia, Anaheim and Milwaukee.
Tropos is also working with Google on a plan to bring free
city-wide wireless access to Mountain View, California,
where Google is based.
Looking Ahead
Boston Millennia Partners wishes to thank all
of our entrepreneurs, advisors, and partners who contributed
to the successes of 2005. Looking ahead to the New Year, we
are encouraged by the significant progress our portfolio
companies have made and the positive momentum with which they
start the New Year. We anticipate that 2006 will be a dynamic
and exciting year for us as we continue to support and grow
our portfolio companies. Please contact us if you feel you
have an investment opportunity Millennia should consider or
you can assist us in helping our companies achieve their
goals.
|
|
|
|
| |

Boston Millennia Partners is a private equity investment
partnership managing over $700 million in capital. From its
offices in Boston, Millennia invests in high-growth businesses
in the healthcare, life sciences, information technology,
business services, and telecommunications industries. Typical
investments range from $3 to $15 million. The managers at
Millennia have funded over 120 companies in the U.S. private
equity market since 1980. Portfolio companies with whom they
have invested include PAREXEL International (NASDAQ: PRXL),
ILEX Oncology (NASDAQ: ILXO), Verio (NASDAQ: VRIO),
Proteome/Incyte Genomics (NASDAQ:INCY), HotJobs/Yahoo (NASDAQ:
YHOO), and CombinatoRx (NASDAQ: CRXX) among others. For more
information, please visit http://www.bmpvc.com/.
Contact: Amy Merk Boston Millennia
Partners 617-428-5150 amy@bmpvc.com
|
|
| |
Boston Millennia Partners
30 Rowes Wharf,
Suite 500 Boston, MA 02110 Phone: 617-428-5150 Fax:
617-428-5160
E-mail: info@bmpvc.com
|
|
|